Stocksigma LogoStocksigma Logo

Insecticides (India) Reports Q2 & H1 FY27 Results With Robust Product Portfolio

Insecticides (India) reported consolidated Q2FY27 revenue of ₹686.31 crore (+8% YoY), EBITDA of ₹92.44 crore (+3% YoY, 13.5% margin), and PAT of ₹56.17

Insecticides (India) Reports Q2 & H1 FY27 Results With Robust Product Portfolio

Insecticides (India) Ltd · Investor Presentation · 05 Nov 2026, 9:43 pm

Insecticides (India) Reports Q2 & H1 FY27 Results With Robust Product Portfolio Insecticides (India) reported consolidated Q2FY27 revenue of ₹686.31 crore (+8% YoY), EBITDA of ₹92.44 crore (+3% YoY, 13.5% margin), and PAT of ₹56.17 crore (-5% YoY). For H1FY27, revenue stood at ₹1,297.84 crore (-2% YoY) with PAT at ₹100.04 crore (-15% YoY). The company expanded premium products to 58% of B2C revenue by FY26. B2C sales mix comprises 49% insecticides, 37% herbicides, 10% fungicides, and 4% biologicals/PGR. Growth strategies focus on R&D collaborations with Corteva and Nissan Chemical, brand expansion via KAEROS, and scaling exports across 22 countries.

Original exchange filing (PDF)

More announcements from Insecticides (India) Ltd

All Insecticides (India) Ltd announcements